Company description
COVID-19, a novel pathogenic coronavirus (2019-nCoV or SARS-CoV2) induced disease, emerged in China and spread globally rapidly. Genemedi is a biotech company with strong expertise in viral vectors mediated gene transfer, gene editing and gene therapy. More detail please visit https://www.genemedi.net/i/recombinant-2019-ncov-antigens-reagents
